
Health care special purpose acquisition companies in 2020-2021 represented a temporary market inefficiency that enabled weaker companies to bypass traditional due diligence and ultimately led to failures.
The American Journal of Managed Care
about 24 years ago
Pill Splittingabout 24 years ago
Antibiotic Resistance: The Iowa Experienceabout 24 years ago
Therapeutic Options for the Management of Type 2 Diabetes Mellitus




